Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study

© 2019 The Author(s). Objective: Age-associated decline in central cholinergic activity makes older adults susceptible to harmful effects of anticholinergics (ACs). Evidence exists of an association between effects of AC medications on cognition. This retrospective cohort study examines how ACs affe...

Full description

Saved in:
Bibliographic Details
Main Authors: Rewadee Jenraumjit, Surarong Chinwong, Dujrudee Chinwong, Tipaporn Kanjanarach, Thanat Kshetradat, Tinakon Wongpakaran, Nahathai Wongpakaran
Format: Journal
Published: 2020
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077387029&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68251
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-68251
record_format dspace
spelling th-cmuir.6653943832-682512020-04-02T15:23:47Z Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study Rewadee Jenraumjit Surarong Chinwong Dujrudee Chinwong Tipaporn Kanjanarach Thanat Kshetradat Tinakon Wongpakaran Nahathai Wongpakaran Biochemistry, Genetics and Molecular Biology © 2019 The Author(s). Objective: Age-associated decline in central cholinergic activity makes older adults susceptible to harmful effects of anticholinergics (ACs). Evidence exists of an association between effects of AC medications on cognition. This retrospective cohort study examines how ACs affect cognition among older adults with Alzheimer's disease (AD) who received acetylcholine esterase inhibitors (AChEIs) over the course of 12 months. Results: A total of 133 (80% women, mean age 78.38 years, SD 7.4) were recruited. No difference in sex, age and comorbid diseases was observed between participants who took ACs, benzodiazepines (BZDs) and AChEIs. The most common prescribed ACs was quetiapine, being used for behavioral and psychological symptoms (BPSD). Multilevel analysis showed that the change of mental state examination scores were significantly predicted in the group using ACs (t (169), - 2.52, p =.020) but not with the groups using BZD (t (162), 0.84, p =.440). Evidence showed that older adults with Alzheimer's disease and exposed to ACs exhibited lower global cognitive scores than those without AC exposure. Using ACs could be a trade-off between controlling BPSD and aggravating cognitive impairment. Highlighting the awareness of the potential anticholinergic effect is important and may be the best policy. 2020-04-02T15:23:47Z 2020-04-02T15:23:47Z 2020-01-02 Journal 17560500 2-s2.0-85077387029 10.1186/s13104-019-4874-z https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077387029&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68251
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Biochemistry, Genetics and Molecular Biology
spellingShingle Biochemistry, Genetics and Molecular Biology
Rewadee Jenraumjit
Surarong Chinwong
Dujrudee Chinwong
Tipaporn Kanjanarach
Thanat Kshetradat
Tinakon Wongpakaran
Nahathai Wongpakaran
Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
description © 2019 The Author(s). Objective: Age-associated decline in central cholinergic activity makes older adults susceptible to harmful effects of anticholinergics (ACs). Evidence exists of an association between effects of AC medications on cognition. This retrospective cohort study examines how ACs affect cognition among older adults with Alzheimer's disease (AD) who received acetylcholine esterase inhibitors (AChEIs) over the course of 12 months. Results: A total of 133 (80% women, mean age 78.38 years, SD 7.4) were recruited. No difference in sex, age and comorbid diseases was observed between participants who took ACs, benzodiazepines (BZDs) and AChEIs. The most common prescribed ACs was quetiapine, being used for behavioral and psychological symptoms (BPSD). Multilevel analysis showed that the change of mental state examination scores were significantly predicted in the group using ACs (t (169), - 2.52, p =.020) but not with the groups using BZD (t (162), 0.84, p =.440). Evidence showed that older adults with Alzheimer's disease and exposed to ACs exhibited lower global cognitive scores than those without AC exposure. Using ACs could be a trade-off between controlling BPSD and aggravating cognitive impairment. Highlighting the awareness of the potential anticholinergic effect is important and may be the best policy.
format Journal
author Rewadee Jenraumjit
Surarong Chinwong
Dujrudee Chinwong
Tipaporn Kanjanarach
Thanat Kshetradat
Tinakon Wongpakaran
Nahathai Wongpakaran
author_facet Rewadee Jenraumjit
Surarong Chinwong
Dujrudee Chinwong
Tipaporn Kanjanarach
Thanat Kshetradat
Tinakon Wongpakaran
Nahathai Wongpakaran
author_sort Rewadee Jenraumjit
title Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
title_short Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
title_full Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
title_fullStr Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
title_full_unstemmed Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: A 1 year follow-up study
title_sort anticholinergics and benzodiazepines on cognitive impairment among elderly with alzheimer's disease: a 1 year follow-up study
publishDate 2020
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077387029&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68251
_version_ 1681426785808416768